Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hyperlipoproteinemia Type IIb”

57 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 57 results

Large-scale testing (Phase 3)Study completedNCT00289900
What this trial is testing

Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024)

Who this might be right for
Mixed Hyperlipidemia
Merck Sharp & Dohme LLC 2,340
Testing effectiveness (Phase 2)Study completedNCT01604824
What this trial is testing

Alirocumab in Participants With Autosomal Dominant Hypercholesterolemia (ADH) and Gain-of-Function Mutations (GOFm) of the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Gene or Loss-of-Function Mutations (LOFm) of the Apolipoprotein (Apo) B Gene

Who this might be right for
Hypercholesterolemia
Regeneron Pharmaceuticals 23
Not applicableStudy completedNCT00005313
What this trial is testing

Human Lipoprotein Pathophysiology - Subproject: Genetics of Familial Combined Hyperlipidemia

Who this might be right for
AtherosclerosisCardiovascular DiseasesHeart Diseases+2 more
University of Washington 450
Large-scale testing (Phase 3)Study completedNCT05532800
What this trial is testing

The Efficacy and Safety of JS002 PFS and AI in Patients With Primary Hypercholesterolemia and Mixed Hyperlipidemia

Who this might be right for
Hyperlipemia
Shanghai Junshi Bioscience Co., Ltd. 255
Large-scale testing (Phase 3)Study completedNCT00139061
What this trial is testing

Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate

Who this might be right for
Hyperlipidemia
Pfizer 128
Post-approval studies (Phase 4)Study completedNCT00552747
What this trial is testing

Effect of Fenofibrate on Endothelial Function and High-density Lipoproteins (HDL)in Patients With Coronary Heart Disease

Who this might be right for
Coronary Heart DiseaseHyperlipidemia
National Heart Institute, Mexico 76
Large-scale testing (Phase 3)Active Not RecruitingNCT07473960
What this trial is testing

IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia

Who this might be right for
Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia
Innovent Biologics (Suzhou) Co. Ltd. 198
Testing effectiveness (Phase 2)Study completedNCT00941603
What this trial is testing

Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675)

Who this might be right for
Primary HypercholesterolemiaMixed Hyperlipidemia
Merck Sharp & Dohme LLC 619
Early research (Phase 1)Study completedNCT00565292
What this trial is testing

MK0859 in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia (MK-0859-011)(COMPLETED)

Who this might be right for
HypercholesterolemiaHyperlipidemia
Merck Sharp & Dohme LLC 50
Large-scale testing (Phase 3)Study completedNCT05255458
What this trial is testing

Evaluate the Long-term Efficacy and Safety of AK102 in Patients With Hyperlipidemia

Who this might be right for
Hyperlipidemia
Akeso 122
Large-scale testing (Phase 3)Looking for participantsNCT07421297
What this trial is testing

Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia

Who this might be right for
Non-familial Hypercholesterolemia and Mixed Hyperlipidemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 760
Post-approval studies (Phase 4)WithdrawnNCT00738985
What this trial is testing

Efficacy of Ezetimibe/Simvastatin 10/20 mg and MK0524A (1-2 g/Day) in Mixed Hyperlipidemia and Two or More Risk Factors

Who this might be right for
Cardiovascular DiseasesHyperlipidemia
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Large-scale testing (Phase 3)Study completedNCT00093899
What this trial is testing

Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)

Who this might be right for
HyperlipidemiaHypercholesterolemiaHypertriglyceridemia
Organon and Co 611
Large-scale testing (Phase 3)Study completedNCT00138762
What this trial is testing

Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol

Who this might be right for
Hyperlipidemia
Pfizer 3,800
Not applicableStudy completedNCT01476436
What this trial is testing

Low Carbohydrate Diet - Effect on Plasma Lipids and Metabolic Markers

Who this might be right for
Overweight and ObesityType IIb HyperlipidaemiaHypercholesterolemia Aggravated
Oslo University Hospital 30
Testing effectiveness (Phase 2)Study completedNCT07421232
What this trial is testing

Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia

Who this might be right for
Hypercholesterolemia and Mixed Hyperlipidemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 156
Post-approval studies (Phase 4)Study completedNCT00473655
What this trial is testing

Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients

Who this might be right for
HypertriglyceridemiaHyperlipoproteinemia Type IVHyperlipoproteinemia Type V+2 more
AstraZeneca 334
Large-scale testing (Phase 3)Not Yet RecruitingNCT07441317
What this trial is testing

QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated Low Density Lipoprotein Cholesterol (LDL-C)

Who this might be right for
Primary Hypercholesterolemia or Mixed Hyperlipidemia
Qilu Pharmaceutical Co., Ltd. 780
Not applicableStudy completedNCT03110432
What this trial is testing

Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry

Who this might be right for
DyslipoproteinemiasHypercholesterolemia, FamilialFamilial Hypercholesterolemia - Homozygous+1 more
GWT-TUD GmbH 1,695
Not applicableStudy completedNCT01555294
What this trial is testing

Evaluation of Non-invasive Measurements of Atherosclerosis in Cardiovascular Risk Stratification

Who this might be right for
Cardiovascular Disease
Radboud University Medical Center 1,960
Next Page